The new artificial intelligence-based software and robot-assisted biopsy technology helps providers catch and treat lung cancer in its earliest stages.
Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...
SurvivorNet on MSN
Targeted therapy in a shot: New approval for EGFR-mutated lung cancer can improve day-to-day life for patients
Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...
From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...
If you smoke and want to quit, call the national quit line at 1-800-784-8669 to speak with a confidential coach. In what ...
Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...
The European Medicines Agency (EMA) recommended eight medicines for approval this month, including two cancer drugs for treating non-small cell lung cancer (NSCLC). The regulatory body's Committee for ...
In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...
A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...
We currently know that COPD, and specifically emphysema, don’t just happen alongside lung cancer; they increase a person’s ...
The study examined 180 patients with advanced lung cancer who received a COVID vaccine within 100 days before or after beginning immunotherapy, as well as 704 similar patients who did not. Vaccinated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback